Personalized medicine has been both a goal and a tagline for the healthcare industry for years. Providing “the right treatment for the right patient at the right time” streamlines clinical paradigms, improves clinical outcomes for patients, and can decrease overall healthcare costs. However, the realization and successful commercialization of personalized medicine is dependent on navigating the scientific, clinical, regulatory, reimbursement and marketing challenges inherent in a market with multiple stakeholders and talent bases. Successful personalized medicine commercialization depends on the thorough analysis of each market under consideration, developing a detailed strategic roadmap by product and program, and leveraging partnerships between multiple stakeholders, including diagnostic, therapeutic, and life science companies, in addition to regulatory authorities and payers.

Health Advances has been successfully advising companies on personalized medicine strategy for the past decade. Our experienced multi-disciplinary team provides therapeutics, diagnostics, and life science companies with innovative commercialization strategies for their personalized medicine products and divisions. Our core competencies include:

  • Corporate strategy
  • Health economic analysis and pricing and reimbursement
  • Market assessment and product positioning
  • Portfolio planning
  • Sales and marketing strategy
  • Transaction due diligence